Halberd Inc (OTCMKTS:HALB) Stock On Watchlist After Recent Developments

January 25, 2022

The biotech sector has always been one of the more popular sectors for investors for many years and it continues to be so. There continue to be lots of intriguing options in the sector that investors could consider looking into and one of those at this point is Halberd Inc (OTCMKTS:HALB). It is regarded as an innovative biotech company and is involved in developing treatment by virtue of the provisional…


Scientific Collaboration and Reseller Agreement Signed by GTX and Halberd (OTCMKTS:HALB)

October 13, 2021

Halberd Corporation and GTX Corp (OTCMKTS:HALB) are coming together to work on several neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s Disease, PTSD/CTE (Chronic Traumatic Encephalopathy)/ Traumatic Brain Injury), among others. Seniors, active duty and veteran soldiers, participants in contact sports and millions of people in general, are susceptible to these diseases, but there is finally some promising news. Both companies plan to combine their technology and expertise in the field…


Halberd Corp (OTCMKTS:HALB) Stock Makes a Bullish Move After The News

August 31, 2021

Publicly traded company on the OTC Market Halberd Corp (OTCMKTS:HALB) on August 30, 2021, gave an update on the Alzheimer’s Disease eradication experimentation. The experimentation is being conducted at Youngstown State University as well as Arizona State University. The company did two rounds on Phosphorylated Tau and its results were astonishing ensuring that researchers are looking to do more tests before publishing in scientific journals. Halberd confirmed that bodily fluids…


Halberd Corporation (OTCMKTS: HALB) Announces New Disease-Causing Antigen Eradication Technique

July 1, 2021

Halberd Corporation (OTCMKTS: HALB) has announced a potentially game-changing technique for removing disease-causing antigen(s) that does not rely on metallic nanoparticles attached to antibodies.  New disease-causing antigens removal technique uses available equipment in hospitals. This more straightforward technique for removing disease-causing antigen(s) makes use of more standard medical equipment available in clinics and hospitals, as well as our patented extracorporeal therapy technique. The strategy is expected to streamline the commercial…